APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefuroxime Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cefuroxime Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchCefuroxime Sodium Injection Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefuroxime Sodium Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Cefuroxime Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefuroxime Sodium Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefuroxime Sodium Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Cefuroxime Sodium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cefuroxime Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cefuroxime Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cefuroxime Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cefuroxime Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cefuroxime Sodium Injection include Aglobal Care, Hikma, Sagent, SteriMax, Teligent, Fresenius Kabi, Guangzhou Baiyunshan Tianxin Pharmaceutical, Sinopharm Weiqida Pharmaceutical and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cefuroxime Sodium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cefuroxime Sodium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cefuroxime Sodium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cefuroxime Sodium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cefuroxime Sodium Injection Segment by Company

Aglobal Care

Hikma

Sagent

SteriMax

Teligent

Fresenius Kabi

Guangzhou Baiyunshan Tianxin Pharmaceutical

Sinopharm Weiqida Pharmaceutical

Harbin Pharmaceutical Group

Pfizer

Shanghai New Asia Pharmacetical

Weikang Pharmaceutical

Youcare Pharmaceutical Group

Cefuroxime Sodium Injection Segment by Type

0.25g/vial

0.5g/vial

0.75g/vial

1.5g/vial

Cefuroxime Sodium Injection Segment by Application

Hospital

Clinic

Others

Cefuroxime Sodium Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefuroxime Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefuroxime Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefuroxime Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cefuroxime Sodium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefuroxime Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cefuroxime Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cefuroxime Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cefuroxime Sodium Injection Industry Trends Table 2. Cefuroxime Sodium Injection Industry Drivers Table 3. Cefuroxime Sodium Injection Industry Opportunities and Challenges Table 4. Cefuroxime Sodium Injection Industry Restraints Table 5. Global Cefuroxime Sodium Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cefuroxime Sodium Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cefuroxime Sodium Injection Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Cefuroxime Sodium Injection Sales Market Share by Manufacturers Table 9. Global Cefuroxime Sodium Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cefuroxime Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cefuroxime Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cefuroxime Sodium Injection Manufacturers, Product Type & Application Table 13. Global Cefuroxime Sodium Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cefuroxime Sodium Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.25g/vial Table 17. Major Manufacturers of 0.5g/vial Table 18. Major Manufacturers of 0.75g/vial Table 19. Major Manufacturers of 1.5g/vial Table 20. Global Cefuroxime Sodium Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Cefuroxime Sodium Injection Sales by Type (2021-2026) & (W Units) Table 22. Global Cefuroxime Sodium Injection Sales by Type (2027-2032) & (W Units) Table 23. Global Cefuroxime Sodium Injection Sales Market Share by Type (2021-2026) Table 24. Global Cefuroxime Sodium Injection Sales Market Share by Type (2027-2032) Table 25. Global Cefuroxime Sodium Injection Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Cefuroxime Sodium Injection Revenue by Type (2021-2026) & (W Units) Table 27. Global Cefuroxime Sodium Injection Revenue by Type (2027-2032) & (W Units) Table 28. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2021-2026) Table 29. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Cefuroxime Sodium Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Cefuroxime Sodium Injection Sales by Application (2021-2026) & (W Units) Table 35. Global Cefuroxime Sodium Injection Sales by Application (2027-2032) & (W Units) Table 36. Global Cefuroxime Sodium Injection Sales Market Share by Application (2021-2026) Table 37. Global Cefuroxime Sodium Injection Sales Market Share by Application (2027-2032) Table 38. Global Cefuroxime Sodium Injection Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Cefuroxime Sodium Injection Revenue by Application (2021-2026) & (W Units) Table 40. Global Cefuroxime Sodium Injection Revenue by Application (2027-2032) & (W Units) Table 41. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2021-2026) Table 42. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2027-2032) Table 43. Global Cefuroxime Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Cefuroxime Sodium Injection Sales by Region (2021-2026) & (W Units) Table 45. Global Cefuroxime Sodium Injection Sales Market Share by Region (2021-2026) Table 46. Global Cefuroxime Sodium Injection Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Cefuroxime Sodium Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Cefuroxime Sodium Injection Sales by Country (2021-2026) & (W Units) Table 50. North America Cefuroxime Sodium Injection Sales by Country (2027-2032) & (W Units) Table 51. Europe Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Cefuroxime Sodium Injection Sales by Country (2021-2026) & (W Units) Table 53. Europe Cefuroxime Sodium Injection Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Cefuroxime Sodium Injection Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Cefuroxime Sodium Injection Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Cefuroxime Sodium Injection Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Cefuroxime Sodium Injection Sales by Country (2027-2032) & (W Units) Table 60. Global Cefuroxime Sodium Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Cefuroxime Sodium Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Cefuroxime Sodium Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Cefuroxime Sodium Injection Revenue Market Share by Region (2021-2026) Table 64. Global Cefuroxime Sodium Injection Revenue Market Share by Region (2027-2032) Table 65. Aglobal Care Company Information Table 66. Aglobal Care Business Overview Table 67. Aglobal Care Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Aglobal Care Cefuroxime Sodium Injection Product Portfolio Table 69. Aglobal Care Recent Development Table 70. Hikma Company Information Table 71. Hikma Business Overview Table 72. Hikma Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Hikma Cefuroxime Sodium Injection Product Portfolio Table 74. Hikma Recent Development Table 75. Sagent Company Information Table 76. Sagent Business Overview Table 77. Sagent Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sagent Cefuroxime Sodium Injection Product Portfolio Table 79. Sagent Recent Development Table 80. SteriMax Company Information Table 81. SteriMax Business Overview Table 82. SteriMax Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. SteriMax Cefuroxime Sodium Injection Product Portfolio Table 84. SteriMax Recent Development Table 85. Teligent Company Information Table 86. Teligent Business Overview Table 87. Teligent Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Teligent Cefuroxime Sodium Injection Product Portfolio Table 89. Teligent Recent Development Table 90. Fresenius Kabi Company Information Table 91. Fresenius Kabi Business Overview Table 92. Fresenius Kabi Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Fresenius Kabi Cefuroxime Sodium Injection Product Portfolio Table 94. Fresenius Kabi Recent Development Table 95. Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information Table 96. Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview Table 97. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Portfolio Table 99. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Development Table 100. Sinopharm Weiqida Pharmaceutical Company Information Table 101. Sinopharm Weiqida Pharmaceutical Business Overview Table 102. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Portfolio Table 104. Sinopharm Weiqida Pharmaceutical Recent Development Table 105. Harbin Pharmaceutical Group Company Information Table 106. Harbin Pharmaceutical Group Business Overview Table 107. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio Table 109. Harbin Pharmaceutical Group Recent Development Table 110. Pfizer Company Information Table 111. Pfizer Business Overview Table 112. Pfizer Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Pfizer Cefuroxime Sodium Injection Product Portfolio Table 114. Pfizer Recent Development Table 115. Shanghai New Asia Pharmacetical Company Information Table 116. Shanghai New Asia Pharmacetical Business Overview Table 117. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Portfolio Table 119. Shanghai New Asia Pharmacetical Recent Development Table 120. Weikang Pharmaceutical Company Information Table 121. Weikang Pharmaceutical Business Overview Table 122. Weikang Pharmaceutical Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Weikang Pharmaceutical Cefuroxime Sodium Injection Product Portfolio Table 124. Weikang Pharmaceutical Recent Development Table 125. Youcare Pharmaceutical Group Company Information Table 126. Youcare Pharmaceutical Group Business Overview Table 127. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio Table 129. Youcare Pharmaceutical Group Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Cefuroxime Sodium Injection Distributors List Table 133. Cefuroxime Sodium Injection Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Cefuroxime Sodium Injection Product Image Figure 2. Global Cefuroxime Sodium Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefuroxime Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefuroxime Sodium Injection Sales (2021-2032) & (W Units) Figure 5. Global Cefuroxime Sodium Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cefuroxime Sodium Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.25g/vial Image Figure 9. 0.5g/vial Image Figure 10. 0.75g/vial Image Figure 11. 1.5g/vial Image Figure 12. Global Cefuroxime Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Cefuroxime Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cefuroxime Sodium Injection Sales Market Share by Type (2021-2032) Figure 15. Global Cefuroxime Sodium Injection Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Cefuroxime Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Cefuroxime Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Cefuroxime Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cefuroxime Sodium Injection Sales Market Share by Application (2021-2032) Figure 24. Global Cefuroxime Sodium Injection Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Cefuroxime Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Cefuroxime Sodium Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Cefuroxime Sodium Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Cefuroxime Sodium Injection Sales Market Share by Country (2021-2032) Figure 41. China Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Cefuroxime Sodium Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Cefuroxime Sodium Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Cefuroxime Sodium Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Cefuroxime Sodium Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Cefuroxime Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Cefuroxime Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Cefuroxime Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Cefuroxime Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cefuroxime Sodium Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cefuroxime Sodium Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g/vial
  • 0.5g/vial
  • 0.75g/vial
  • 1.5g/vial
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Aglobal Care
  • Hikma
  • Sagent
  • SteriMax
  • Teligent
  • Fresenius Kabi
  • Guangzhou Baiyunshan Tianxin Pharmaceutical
  • Sinopharm Weiqida Pharmaceutical
  • Harbin Pharmaceutical Group
  • Pfizer
  • Shanghai New Asia Pharmacetical
  • Weikang Pharmaceutical
  • Youcare Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cefuroxime Sodium Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cefuroxime Sodium Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cefuroxime Sodium Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cefuroxime Sodium Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cefuroxime Sodium Injection Market Dynamics
  1. 2.1 Cefuroxime Sodium Injection Industry Trends
  2. 2.2 Cefuroxime Sodium Injection Industry Drivers
  3. 2.3 Cefuroxime Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Cefuroxime Sodium Injection Industry Restraints
3 Cefuroxime Sodium Injection Market by Manufacturers
  1. 3.1 Global Cefuroxime Sodium Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cefuroxime Sodium Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cefuroxime Sodium Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cefuroxime Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefuroxime Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cefuroxime Sodium Injection Manufacturers, Product Type & Application
  7. 3.7 Global Cefuroxime Sodium Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefuroxime Sodium Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefuroxime Sodium Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefuroxime Sodium Injection Tier 1, Tier 2, and Tier 3
4 Cefuroxime Sodium Injection Market by Type
  1. 4.1 Cefuroxime Sodium Injection Type Introduction
  2. 4.1.1 0.25g/vial
  3. 4.1.2 0.5g/vial
  4. 4.1.3 0.75g/vial
  5. 4.1.4 1.5g/vial
  6. 4.2 Global Cefuroxime Sodium Injection Sales by Type
  7. 4.2.1 Global Cefuroxime Sodium Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cefuroxime Sodium Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Cefuroxime Sodium Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cefuroxime Sodium Injection Revenue by Type
  11. 4.3.1 Global Cefuroxime Sodium Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cefuroxime Sodium Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Cefuroxime Sodium Injection Revenue Market Share by Type (2021-2032)
5 Cefuroxime Sodium Injection Market by Application
  1. 5.1 Cefuroxime Sodium Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cefuroxime Sodium Injection Sales by Application
  6. 5.2.1 Global Cefuroxime Sodium Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cefuroxime Sodium Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Cefuroxime Sodium Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cefuroxime Sodium Injection Revenue by Application
  10. 5.3.1 Global Cefuroxime Sodium Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cefuroxime Sodium Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Cefuroxime Sodium Injection Revenue Market Share by Application (2021-2032)
6 Global Cefuroxime Sodium Injection Sales by Region
  1. 6.1 Global Cefuroxime Sodium Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cefuroxime Sodium Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cefuroxime Sodium Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Cefuroxime Sodium Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cefuroxime Sodium Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cefuroxime Sodium Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cefuroxime Sodium Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cefuroxime Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cefuroxime Sodium Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cefuroxime Sodium Injection Revenue by Region
  1. 7.1 Global Cefuroxime Sodium Injection Revenue by Region
  2. 7.1.1 Global Cefuroxime Sodium Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cefuroxime Sodium Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Cefuroxime Sodium Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Cefuroxime Sodium Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cefuroxime Sodium Injection Revenue (2021-2032)
  8. 7.2.2 North America Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cefuroxime Sodium Injection Revenue (2021-2032)
  11. 7.3.2 Europe Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cefuroxime Sodium Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cefuroxime Sodium Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cefuroxime Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aglobal Care
  2. 8.1.1 Aglobal Care Company Information
  3. 8.1.2 Aglobal Care Business Overview
  4. 8.1.3 Aglobal Care Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aglobal Care Cefuroxime Sodium Injection Product Portfolio
  6. 8.1.5 Aglobal Care Recent Developments
  7. 8.2 Hikma
  8. 8.2.1 Hikma Company Information
  9. 8.2.2 Hikma Business Overview
  10. 8.2.3 Hikma Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hikma Cefuroxime Sodium Injection Product Portfolio
  12. 8.2.5 Hikma Recent Developments
  13. 8.3 Sagent
  14. 8.3.1 Sagent Company Information
  15. 8.3.2 Sagent Business Overview
  16. 8.3.3 Sagent Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sagent Cefuroxime Sodium Injection Product Portfolio
  18. 8.3.5 Sagent Recent Developments
  19. 8.4 SteriMax
  20. 8.4.1 SteriMax Company Information
  21. 8.4.2 SteriMax Business Overview
  22. 8.4.3 SteriMax Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SteriMax Cefuroxime Sodium Injection Product Portfolio
  24. 8.4.5 SteriMax Recent Developments
  25. 8.5 Teligent
  26. 8.5.1 Teligent Company Information
  27. 8.5.2 Teligent Business Overview
  28. 8.5.3 Teligent Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teligent Cefuroxime Sodium Injection Product Portfolio
  30. 8.5.5 Teligent Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Cefuroxime Sodium Injection Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 Guangzhou Baiyunshan Tianxin Pharmaceutical
  38. 8.7.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
  39. 8.7.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview
  40. 8.7.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
  42. 8.7.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments
  43. 8.8 Sinopharm Weiqida Pharmaceutical
  44. 8.8.1 Sinopharm Weiqida Pharmaceutical Company Information
  45. 8.8.2 Sinopharm Weiqida Pharmaceutical Business Overview
  46. 8.8.3 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
  48. 8.8.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  49. 8.9 Harbin Pharmaceutical Group
  50. 8.9.1 Harbin Pharmaceutical Group Company Information
  51. 8.9.2 Harbin Pharmaceutical Group Business Overview
  52. 8.9.3 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
  54. 8.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Cefuroxime Sodium Injection Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Shanghai New Asia Pharmacetical
  62. 8.11.1 Shanghai New Asia Pharmacetical Company Information
  63. 8.11.2 Shanghai New Asia Pharmacetical Business Overview
  64. 8.11.3 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Portfolio
  66. 8.11.5 Shanghai New Asia Pharmacetical Recent Developments
  67. 8.12 Weikang Pharmaceutical
  68. 8.12.1 Weikang Pharmaceutical Company Information
  69. 8.12.2 Weikang Pharmaceutical Business Overview
  70. 8.12.3 Weikang Pharmaceutical Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Weikang Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
  72. 8.12.5 Weikang Pharmaceutical Recent Developments
  73. 8.13 Youcare Pharmaceutical Group
  74. 8.13.1 Youcare Pharmaceutical Group Company Information
  75. 8.13.2 Youcare Pharmaceutical Group Business Overview
  76. 8.13.3 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
  78. 8.13.5 Youcare Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cefuroxime Sodium Injection Value Chain Analysis
  2. 9.1.1 Cefuroxime Sodium Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cefuroxime Sodium Injection Production Mode & Process
  6. 9.2 Cefuroxime Sodium Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cefuroxime Sodium Injection Distributors
  9. 9.2.3 Cefuroxime Sodium Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst